drugset / Trial / NCT02621073

VeraFlo With Prontosan® and Wound and Fracture Healing.

NCT02621073

Terminated 7 enrolled Brett Crist
RandomizedParallel-groupOpen-labelTreatment

Summary

To answer the question: "Do Prontosan instillations decrease time to wound and fracture healing and decrease bacterial load compared to wound vac treatment without Prontosan?," we will enroll up to 30 subjects (for an anticipated 20 complete data sets) into this trial. The subjects will be split equally into two different groups by randomization. One groups will have wound vac therapy with Prontosan, and one group will have wound vac therapy without Prontosan. Data related to wound and fracture healing and bacterial load will be assessed between the two groups to determine if wound vac therapy with Prontosan speeds up healing time and decreases bacterial load.

Timeline

Start
2015-11
Primary completion
2017-12
Completion
2017-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Polihexanide Other / unclassified

Indications